Literature DB >> 32597341

Role of platelets and megakaryocytes in adaptive immunity.

Genevieve Marcoux1,2,3, Audrée Laroche1,2,3, Jenifer Espinoza Romero1,2,3, Eric Boilard1,2,3.   

Abstract

The immune system is comprised of two principal interconnected components called innate and adaptive immunity. While the innate immune system mounts a nonspecific response that provides protection against the spread of foreign pathogens, the adaptive immune system has developed to specifically recognize a given pathogen and lead to immunological memory. Platelets are small fragments produced from megakaryocytes in bone marrow and lungs. They circulate throughout the blood to monitor the integrity of the vasculature and to prevent bleeding. Given their large repertoire of immune receptors and inflammatory molecules, platelets and megakaryocytes can contribute to both innate and adaptive immunity. In adaptive immunity, platelets and megakaryocytes can process and present antigens to lymphocytes. Moreover, platelets, via FcγRIIA, rapidly respond to pathogens in an immune host when antibodies are present. This manuscript reviews the reported contributions of platelets and megakaryocytes with emphasis on antigen presentation and antibody response in adaptive immunity.

Entities:  

Keywords:  Adaptive immunity; FcγRIIA; antibody; antigen; megakaryocytes; platelets

Year:  2020        PMID: 32597341     DOI: 10.1080/09537104.2020.1786043

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  9 in total

1.  Interactions with Asialo-Glycoprotein Receptors and Platelets Are Dispensable for CD8+ T Cell Localization in the Murine Liver.

Authors:  James H O'Connor; Hayley A McNamara; Yeping Cai; Lucy A Coupland; Elizabeth E Gardiner; Christopher R Parish; Brendan J McMorran; Vitaly V Ganusov; Ian A Cockburn
Journal:  J Immunol       Date:  2022-06-01       Impact factor: 5.426

2.  Bioinformatics of Differentially Expressed Genes in Phorbol 12-Myristate 13-Acetate-Induced Megakaryocytic Differentiation of K562 Cells by Microarray Analysis.

Authors:  Seung-Hoon Lee; Na Rae Park; Jung-Eun Kim
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

Review 3.  Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets?

Authors:  Robert A Campbell; Eric Boilard; Matthew T Rondina
Journal:  J Thromb Haemost       Date:  2020-11-18       Impact factor: 5.824

Review 4.  What Function Do Platelets Play in Inflammation and Bacterial and Viral Infections?

Authors:  Beata Tokarz-Deptuła; Joanna Palma; Łukasz Baraniecki; Michał Stosik; Roman Kołacz; Wiesław Deptuła
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 7.561

5.  Study on the Clinical Implications of NLR and PLR for Diagnosing Frailty in Maintenance Hemodialysis Patients and Their Correlations with Patient Prognosis.

Authors:  Jun Wang; Lijuan Huang; Meichang Xu; Lei Yang; Xu Deng; Bei Li
Journal:  J Healthc Eng       Date:  2022-01-12       Impact factor: 2.682

Review 6.  Platelet extracellular vesicles in COVID-19: Potential markers and makers.

Authors:  Florian Puhm; Louis Flamand; Eric Boilard
Journal:  J Leukoc Biol       Date:  2021-11-03       Impact factor: 6.011

7.  Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells.

Authors:  Florian Puhm; Isabelle Allaeys; Emile Lacasse; Isabelle Dubuc; Yannick Galipeau; Younes Zaid; Loubna Khalki; Clemence Belleannée; Yves Durocher; Alain R Brisson; Alisa S Wolberg; Marc-André Langlois; Louis Flamand; Eric Boilard
Journal:  Blood Adv       Date:  2022-06-28

8.  The ongoing enigma of SARS-CoV-2 and platelet interaction.

Authors:  Younes Zaid; Fadila Guessous
Journal:  Res Pract Thromb Haemost       Date:  2022-01-25

9.  The Toll-Like Receptor 2 Ligand Pam2CSK4 Activates Platelet Nuclear Factor-κB and Bruton's Tyrosine Kinase Signaling to Promote Platelet-Endothelial Cell Interactions.

Authors:  Iván Parra-Izquierdo; Hari Hara Sudhan Lakshmanan; Alexander R Melrose; Jiaqing Pang; Tony J Zheng; Kelley R Jordan; Stéphanie E Reitsma; Owen J T McCarty; Joseph E Aslan
Journal:  Front Immunol       Date:  2021-08-30       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.